{"id":616360,"title":"Qualifying notice: Pemazyre - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T19:42:44.724000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-pemazyre-242569.html","snippet":"Qualifying notice: Pemazyre Therapeutic Products Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa, Ontario K1A 0K9 Dossier ID: e242569 [employee name removed] [employee title removed] Incyte Corporation 1801 Augustine Cut-Off…","rawSnapshotUrl":"/api/snapshots/raw/616360","browseUrl":"https://replay.healtharchive.ca/job-6/20260302194244/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-pemazyre-242569.html#ha_snapshot=616360","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}